Antibody Drug Conjugate Drug Market

Antibody Drug Conjugate Drug Market contains market size and forecasts of Antibody Drug Conjugate (ADC) Drug in Global, including the following market information:

• Global Antibody Drug Conjugate (ADC) Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Antibody Drug Conjugate (ADC) Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibody Drug Conjugate (ADC) Drug include Oxford Bio Therapeutics, Synthon, Progenics Pharmaceuticals, Bayer HealthCare, Millennium Pharmaceuticals, Pfizer, Concortis Bio therapeutics, Roche Holding AG and Seattle Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antibody Drug Conjugate (ADC) Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Drug Conjugate (ADC) Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, by Type, 2021 (%)

by Technology

• Mmunomedics Technology
• Immunogen Technology
• Seattle Genetics Technology
• Others

by Product Type

• Kadcyla
• Adcertis

Global Antibody Drug Conjugate (ADC) Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, by Application, 2021 (%)

• Biotechnology Companies
• Specialized Cancer Centers
• Biopharmaceutical Companies
• Academic Research Institutes
• Hospitals
• Others

Global Antibody Drug Conjugate (ADC) Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Antibody Drug Conjugate (ADC) Drug revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Antibody Drug Conjugate (ADC) Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Oxford Bio Therapeutics
• Synthon
• Progenics Pharmaceuticals
• Bayer HealthCare
• Millennium Pharmaceuticals
• Pfizer
• Concortis Bio therapeutics
• Roche Holding AG
• Seattle Genetics
• Heidelberg Pharma
• Mersana Therapeutics
• Astellas Pharma/Agensys
• AbbVie Inc
• Celldex Therapeutics
• Immunomedics
• Agensys
• Genentech
• ImmunoGen
• Sanofi
• Genmab
• Amgen
• Novartis
• Eli Lilly